Greenberg Traurig

Greenberg Traurig shareholders Bob Grossman and Josh Samek, along with ex-partner Ira Rosner (now with Holland & Knight), led an 11-attorney team that guided OPKO Health Inc. in its $1.47 billion acquisition in August 2015 of Bio-Reference Laboratories, one of the largest and fastest growing full service diagnostic laboratory companies on the globe. In the all-stock deal, Bio-Reference shareholders received 2.75 shares of OPKO common stock for each share of Bio-Reference common stock. Both firms are publicly traded.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]